REVIEWS   (Open Access)

The Power of Peptides: The Precision Molecules of Life 

John A. Catanzaro

+ Author Affiliations

Journal of Precision Biosciences 3(1) 1-6 https://doi.org/10.25163/biosciences.312000

Submitted: 01 December 2020  Revised: 30 December 2020  Published: 01 January 2021 

Short peptide self-assembly can be potent molecules, particularly in
the precision / personalized medicine arena. 

Abstract

In this review, a brief discussion of peptides, polypeptides, and their self-assembly architecture as a diverse platform for precision and personalized medicine. Self-assembly is a vital force of nature. The self-assembly process of the peptide chains is dynamic — reassembly repeatedly occurs in a self-healing manner. The interactions that happen to reassemble peptide structures include van der Waals forces, ionic bonds, hydrogen bonds, and hydrophobic forces. These forces also facilitate the molecular recognition function that the peptides encompass. 

References

G. W. Beadle and E. L. Tatum, Genetic Control of Biochemical Reactions in Neurospora, (1941, 27 (11), 499-506, https://doi.org/10.1073/pnas.27.11.499

 

Jordana Cepelewicz, (2017), Life’s First Molecule Was Protein, Not RNA, New Model Suggests, Quanta Magazine.

 

Carny, O., and Gazit, E. (2005). A model for the role of short self-assembled peptides in the very early stages of the origin of life. FASEB J. 19, 1051–1055. doi: 10.1096/fj.04-3256hyp

 

Zaucha J, Heddle JG. Resurrecting the Dead (Molecules). Comput Struct Biotechnol J. 2017 May 30;15:351-358. doi: 10.1016/j.csbj.2017.05.002. PMID: 28652896; PMCID: PMC5472138.

 

Bernard M.A.G. Piette, Jonathan G. Heddle, (2020), A Peptide–Nucleic Acid Replicator Origin for Life, Trends in Ecology & Evolution, 35(5), 397-406.

 

Gupta Seema, Singh Indu, Sharma Ashwani K., Kumar Pradeep, (2020), Ultrashort Peptide Self-Assembly: Front-Runners to Transport Drug and Gene Cargos, Frontiers in Bioengineering and Biotechnology, 8  

 

Catanzaro JA, Yuryev A, Sultan Khan MS Treatment using SOLVx-COVID-19 in a preclinical animal model with a broad-surveillance pooled-peptide therapeutic strategy against multiple viral proteins of SARS-COV2 mutant, ASGCT (published in 2021, Cell Press, Molecular Therapy Journal)

PDF
Full Text
Export Citation

View Dimensions


View Plumx



View Altmetric



0
Save
0
Citation
720
View
0
Share